3 ob 5 - postterm pregnancy and fetal growth disorders
TRANSCRIPT
Group#28| Zabetty, Lea, and Mark Villanueva Page 1 of 5
Obstetrics 3.5
Postterm Pregnancy and Fetal Growth Disorders
Dr. Salud September 18, 2014
OUTLINE I. Postterm Pregnancy II. Fetal Growth Disorders
a. Intrauterine Growth Restriction b. Macrosomia
REFERENCES 1. Dr. Salud’s lecture and PPT 2. Williams Obstetrics 24th Edition NOTE: Unless otherwise specified, the information from this trans came from the PowerPoint.
POSTTERM PREGNANCY
Delivery of a fetus at 42 completed weeks/294 days or greater from the LMP
Factors affecting diagnostic accuracy: o Wrong or unrecalled LMP o Biological variations in menstrual cycle and ovulation dates
Confirmatory Test: Early Sonography o To date pregnancy done o Preferable in the 1st trimester o Can also be done before the 24th week of pregnancy but error in
estimation is increased
Incidence: approximately 6% of 4 million infants born in the US are born postterm
Predisposing factors o Maternal
Prepregancy BMI >/= 25 Nulliparity Prior Postterm
o Fetoplacental Anencephaly – no fetal head to help dilate the cervix Adrenal hypoplasia Placental sulfatase deficiency
Outcome of postterm pregnancies o Uncompromised placental function which might probably lead to
continued fetal growth — Macrosomia o Placental dysfunction leading to postmaturity syndrome (10%) o Perinatal mortality rates increase after the expected due date has
passed 2
Postmaturity Syndrome o Wrinkled (particularly prominent on palms and soles), patchy,
peeling skin o Long, thin body suggesting wasting o Advanced maturity because the infant is open-eyed, unusually
alert, and appears old and worried o Typically has long nails o Looks like Benjamin Button
Associated pathophysiologic factors o Loss of vernix caseosa o Placental senescence with cell death leading to decreased fetal
oxygenation o Oligohydramnios (10-33%) - scanty amniotic fluid, which can be
assessed by USG (Amniotic fluid index [AFI] ≤5) o Cord compression with non-reassuring fetal heart rate patterns
(e.g. saltatory baseline) o Scanty and viscous meconium which might lead to meconium
aspiration syndrome (most common indication for aggressive management)
o Fetal growth restriction - stillbirths were more common among growth-restricted infants who were delivered after 42 weeks; 33% of postterm stillbirth infants were growth restricted
Major causes of maternal and perinatal mortalities in postterm pregnancy: o Gestational HPN o Prolonged labor with cephalopelvic disproportion o Unexplained anoxia o Fetal malformations
Specific causes of death o Birth asphyxia o Meconium aspiration
Pregnancy Outcomes o Maternal
Increased rate of Cesarean Section Intrapartum complications Medical complications associated with gestational
hypertension and diabetes o Fetal
Increased perinatal morbidity and mortality Fetal distress Shoulder dystocia for big babies Neonatal Seizures Increased admissions to neonatal intensive care Increase in the number of long term developmental
anomalies and abnormalities
MANAGEMENT OF POSTTERM PREGNANCY Management Controversies
Type of intervention and timing of use
The decision centers on whether labor induction is necessary or if expectant management with fetal surveillance is best.
Acceptable indications of earlier intervention or delivery: o Gestational hypertensive disorders o Previous C-section o Diabetes o Oligohydramnios o Fetal compromise – e.g. saltatory patterns on electric heart rate
monitoring Management Strategies
Induction of Labor o Factors affecting success
Favourability of the cervix Bishop score of 7 or more Cervical dilatation Cervical length (estimated by USG: < 3 cm or 25 mm long) Station of the vertex (The Cesarean delivery rate was directly
related to station. It was 6% if the vertex before induction was at −1 station; 20% at −2; 43% at −3; and 77% at –4)2
o Management of unfavourable cervix Ripen with Prostaglandin E2 gel or Mifeprestone Stripping of the membranes
Fetal Surveillance starting at 41 weeks o Fetal movement counting at 2 hour period per day o Nonstress test 3x per week o Amniotic Fluid Volume estimation 2-3x per week
pockets < 3 cm is considered abnormal2
Management Recommendations
The American College of Obstetricians and Gynecologists defines postterm pregnancies as having completed 42 weeks.2
There is insufficient evidence to recommend a management strategy between 40 and 42 completed weeks. Thus, although not considered mandatory, initiation of fetal surveillance at 41 weeks is a reasonable option.2
Group# 28 Zabetty, Lea, and Mark Villanueva| Page 2 of 5
OBSTETRICS 3.3
After completing 42 weeks, recommendations are for either antenatal testing or labor induction. Prostaglandins may be used for cervical ripening or induction.2 (see Fig. 1)
Figure 1. Management of Post-term Pregnancy.
a see text on Management Strategies. b Prostaglandins may be used Intrapartum Management
Treated as high risk pregnancy
Women whose pregnancies are known or suspected to be postterm should come to the hospital as soon as they suspect labor. 2
While being evaluated for active labor, we recommend that fetal heart rate and uterine contractions be monitored electronically for variations consistent with fetal compromise.2
The decision to perform amniotomy is problematic. 2 o Further reduction in fluid volume following amniotomy can
certainly enhance the possibility of cord compression.2 o However it will aid in the identification of thickly stained
meconium, which may be dangerous to the fetus if aspirated o Also, after membrane rupture, a scalp electrode and intrauterine
pressure catheter can be placed, which usually provide more precise data concerning fetal heart rate and uterine contractions.2
Identification of thick meconium in the amnionic fluid is particularly worrisome.
If you rupture the bag of water and there is thickly stained meconium and very scanty amniotic fluid volume, you may do remedial measures.
Remedial measures for thick meconium and oligohydramnios o Amnioinfusion
introduction of sterile NSS toward the intrauterine cavity through the cervix to dilute the meconium
According to the American College of Obstetricians and Gynecologists, amnioinfusion does not prevent meconium aspiration, however, it remains a reasonable treatment approach for repetitive variable decelerations2
o C-section should be strongly considered for thick meconium when patient is remote from delivery Especially when cephalopelvic disproportion is suspected or
either hypotonic or hypertonic dysfunctional labor is evident.2
Management of Meconium Aspiration o The American College of Obstetricians and Gynecologists does not
recommend routine intrapartum suctioning.2 o Alternatively, if the depressed newborn has meconium-stained
fluid, then intubation is carried out. The American Academy of Pediatrics states that tracheal suctioning is neither supported nor refuted.2
FETAL GROWTH DISORDERS
Human fetal growth is characterized by sequential patterns of tissue and organ growth, differentiation, and maturation
Factors involved in development: o Maternal provision of substrate especially glucose o Placental transfer of nutrients o Fetal growth potential (genes)
Table 1. Three Phases of Cell Growth
PHASE DETERMINANTS
HYPERPLASIA First 16 weeks
Increase in cell number FETAL GENOME
HYPERPLASIA + HYPERTROPHY 17-32 weeks
ENVIRONMENTAL NUTRITIONAL HORMONAL
HYPERTROPHY When most fetal fat and glycogen
are accumulated After 32 weeks
“When IUGR is best diagnosed”
INTRAUTERINE GROWTH RESTRICTION (IUGR)
Low-birthweight infants who are small-for-gestational age (with birthweights falling below the 10th percentile of weight expected for gestational age)2
Birthweight may be affected by normal biological factors like ethnicity, regional differences, parity, weight and height of parents
Figure 2. Smoothed Percentiles of Birthweight (g) for Gestational Age in the
United States. Based on 3,134,879 Singleton Live Births
They are at a higher risk for fetal morbidities and mortalities o Fetal demise, birth asphyxia, meconium aspiration, neonatal
hypoglycemia
Postnatal prognosis of growth restricted fetuses is affected by: o Causes of restriction
Restriction due to chromosomal, viral or maternal size – remains small throughout life (“stunted growth”)
Restriction due to placental insufficiency – increase growth and approach their growth potential (“baby will catch up if nutrition is good”)
o Nutrition in infancy o Social Environment
Group# 28 Zabetty, Lea, and Mark Villanueva| Page 3 of 5
OBSTETRICS 3.3
Classification (based on HC/AC ratio)
Symmetrical o Reduced head and body size o Usually occurs in infections o Early insult - for example, global insults such as from chemical
exposure, viral infection, or cellular maldevelopment with aneuploidy may cause a proportionate reduction of both head and body size
o Results in decreased cell number and size
Asymmetrical o Reduced body size o Late pregnancy insult (e.g. placental insufficiency from
hypertension) o Decreased cell size only o Brain sparing – normal head size and growth; “most of the blood
will flow of the head which is more important than the body of the fetus”
Risk Factors
Constitutionally small mother o <100 lbs –2x risk of delivering SGA infant o “When mothers want to maintain their sexiness”
Poor maternal nutrition o low BMI and poor weight gain especially in the 2nd trimester o gestational weight gain during the second and third trimesters
that was less than that recommended by the Institute of Medicine was associated with SGA neonates in women of all weight categories except class II or III obesity2
Social deprivation o lifestyle—smoking, addiction, and poor nutrition
Maternal and fetal infection o CMV – direct cytolysis and loss of functional cells
most of these babies will not survive o Rubella – reduction in cell division and produces vascular
insufficiency most will still be delivered
Congenital malformations o the more severe the malformation the more likely is the fetal IUGR
Chromosomal Aneuploidies o Trisomy 21—mild IUGR o Trisomy 18—severe IUGR o Trisomy 16—fatal
Teratogens o Anticonvulsants, antineoplastic
Vascular Disease o superimposed pre-eclampsia o chronic hypertension
Pre-gestational Diabetes o Maternal vascular disease (fetal substrate deprivation)
Chronic Hypoxia o Uteroplacental hypoxia: preeclampsia, chronic hypertension,
asthma, smoking, high altitude (those that live in high altitude are usually smaller than those living in sea level)
Placental & Cord Abnormalities o Chorioangioma, marginal or velamentous cord insertion,
circumvallate placenta o This will lessen the flow of substrate oxygen to your fetus
Antiphospholipid Antibody Syndrome o Adverse obstetrical outcomes including fetal-growth restriction
have been associated with three species of antiphospholipid antibodies: anticardiolipin antibodies, lupus anticoagulant, and antibodies against beta-2-glycoprotein-I
o Antibodies—maternal platelet aggregation & plasma thrombosis
Genetics o Inheritance of certain substance that interfere with folate
metabolism
Multiple Fetuses o The higher the number of fetuses in the mother’s womb the
higher the chance it will affect the growth of the fetuses
Identification of IUGR
Fundic height measurement o At 18-30 weeks, fundic height in centimeters should coincide with
2 weeks of gestational age o Thus, if the measurement is more than 2 to 3 cm from the
expected height, inappropriate fetal growth is suspected
Sonographic Measurements o 16-20 weeks for identification of anomalies o 32-34 weeks for growth monitoring o Establish the diagnosis of IUGR by:
Femur length Biparietal Diameter Abdominal Circumference (most commonly abnormal in IUGR
because soft tissue is involved)
Amniotic Fluid Measurement o For determination of associated oligohydramnios
Doppler Velocity on fetal vessels with the following results: o Umbilical Artery/ Middle Cerebral Artery abnormality
mild dysfunction detects early changes in placenta-based growth restriction
o Ductus Venosus or Aorta Abnormalities detects late changes progressive dysfunction
Figure 3. Doppler velocimetry. (A) Normal velocimetry pattern with a systolic to diastolic (S/D) ratio of <3. (B) The diastolic velocity approaching zero reflects increased placental vascular resistance. (C) During diastole, arterial flow is reversed (negative S/D ratio), which is an ominous sign that may precede fetal demise.
Prevention
Preconceptional counseling on risk factors
Correction of nutritional deficiencies
Prophylaxis in early gestation with low dose aspirin (effective only in 10% of cases)
Management
Guidelines o Confirm diagnosis o Assess fetal condition by surveillance o Evaluate for anomalies
≥ 34 weeks: Prompt delivery o Vaginal delivery for reassuring Fetal Heart Rate (FHR) pattern o Caesarean Section (CS) for non-reassuring FHR during labor
Group# 28 Zabetty, Lea, and Mark Villanueva| Page 4 of 5
OBSTETRICS 3.3
< 34 weeks o Observation & monitoring until fetal maturity is attained o Qualifications:
Normal fetus Normal AFI (amniotic Fluid Index) Normal fetal surveillance Fetal growth continues
Management decisions must be based on relative risks of fetal death with expectant management or risks from preterm delivery
Conduct of Labor & Delivery
High risk intrapartum monitoring
Watch out for fetal decompensation
Immediate care of the newborn for: o Hypoxia o Meconium aspiration o Hypothermia o Hypoglycemia
MACROSOMIA
Infants above the 90th percentile for a given age of gestation or newborns weighing >4000g o ACOG: Fetuses who weigh 4500g or more at birth
Risk Factors: o Obesity o Gestational diabetes and DM type 2 o Postterm gestation o Multiparity o Large size of parents o Advancing maternal age o Previous macrosomic infant o Racial & ethnic factors
Diagnosis o Sonographic fetal weight estimation - head, femur & abdominal
circumference However, sonography can also make a mistake. If you are
going to assess the fetal weight at a later gestation, it should be +/- 500g.
Routine use to identify macrosomia is not recommended Findings of several studies indicate that clinical fetal-weight
estimates are as reliable as, or even superior to, those made from sonographic measurements
o Clinical estimate by PE Inaccuracy is often attributable to maternal obesity
Management o Trial of Labor
Concern: possible shoulder dystocia resulting into brachial plexus injury (brachial plexus palsy)
o Planned Cesarian Section A reasonable strategy for diabetic women with estimated
fetal weight ≥4250g planned cesarean delivery on the basis of suspected
macrosomia to prevent brachial plexopathy is an unreasonable strategy in the general population2
o In summary, when fetal overgrowth is suspected, the obstetrician naturally seeks to balance the risks to the fetus with maternal risks. 2
o Although interventions to prevent shoulder dystocia may someday prove beneficial, eliminating shoulder dystocia will likely remain an impossible goal. 2
o For the American College of Obstetricians and Gynecologists, elective delivery for the fetus that is suspected to be overgrown is inadvisable, particularly before 39 weeks’ gestation. 2
o Elective cesarean delivery is not indicated when estimated fetal weight is <5000 g among women without diabetes and < 4500 g among women with diabetes.2
Edited by: Venus Rojas